Eli Lilly and Novo Nordisk are fighting to capture the weight-loss drug market. Amazon could complicate things.

Imagine if losing weight were as simple as swallowing a daily pill-no needles, no injections and no anxiety. If you're among the 25 percent of adults who fear needles, per Harvard Health, or if ...

The rise of GLP‑1 medications may accelerate long‑needed changes in the food system, pushing companies to rethink flavor, texture, portioning and even the definition of enjoyment itself. The rise of ...

Weight loss drugs like GLP-1s are rapidly reshaping how Americans think about appetite, health and food – forcing CPG brands to reconsider everything from formulation to front-of-pack messaging.

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...